SPOTLIGHT -
Roche Makes $44B Offer for Control of Genentech
After years of owning a majority share in Genentech, Roche makes a play to buy out the rest of the biotech firm.
BMS Settlement Cash Distributed
Bristol-Meyers Squibb will pay more than half a billion dollars to settle charges that it illegally promoted the sale of the anti-psychotic drug Abilify for off-label uses.
